TCRX

TCRX

USD

TScan Therapeutics Inc. Common Stock

$1.120-0.050 (-4.274%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.170

最高价

$1.250

最低价

$1.080

成交量

0.81M

公司基本面

市值

63.6M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.51M

交易所

NGM

货币

USD

52周价格范围

最低价 $1.02当前价 $1.120最高价 $6.225

相关新闻

Analyst Upgrades

BTIG Downgrades TScan Therapeutics to Neutral

BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.

查看更多
BTIG Downgrades TScan Therapeutics to Neutral
Analyst Upgrades

Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6

Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.

查看更多
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
GlobeNewswire

TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027

Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;

查看更多
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027